Net Loss per Share (Tables)

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Schedule of Antidilutive Shares Excluded From Calculation of Diluted Net Loss Per Share

	Three Months Ended June 30,		Six Months Ended June 30,
	2023	2022	2023	2022
Shares issuable upon conversion of SPA Notes and settlement of make-whole provisions	648,065,080	9,009,166	648,065,080	9,009,166
Shares issuable upon exercise of SPA Warrants	112,780,647	—	112,780,647	—
Other warrants	29,454,593	4,544,258	29,454,593	4,544,258
Stock-based compensation awards – Options	35,280,854	40,730,358	35,280,854	40,730,358
Stock-based compensation awards – RSUs	16,520,514	—	16,520,514	—
Public warrants	23,540,988	22,977,568	23,540,988	22,977,568
Private warrants	111,131	674,551	111,131	674,551
Total	865,753,807	77,935,901	865,753,807	77,935,901